Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.

Homozygous mutations in EVER genes cause epidermodysplasia verruciformis (EV), characterized by an immune defect and the development of skin cancers associated with β-human papillomavirus (HPV) infections. The effects of EVER protein loss on the keratinocyte immune response remain unknown. We show h...

Full description

Bibliographic Details
Main Authors: Françoise Vuillier, Guillaume Gaud, Delphine Guillemot, Pierre-Henri Commere, Christian Pons, Michel Favre
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586810/?tool=EBI
_version_ 1818402226343772160
author Françoise Vuillier
Guillaume Gaud
Delphine Guillemot
Pierre-Henri Commere
Christian Pons
Michel Favre
author_facet Françoise Vuillier
Guillaume Gaud
Delphine Guillemot
Pierre-Henri Commere
Christian Pons
Michel Favre
author_sort Françoise Vuillier
collection DOAJ
description Homozygous mutations in EVER genes cause epidermodysplasia verruciformis (EV), characterized by an immune defect and the development of skin cancers associated with β-human papillomavirus (HPV) infections. The effects of EVER protein loss on the keratinocyte immune response remain unknown. We show here that EVER2 plays a critical role in the interplay between the NF-κB and JNK/AP-1 signaling pathways. EVER2-deficient cells overproduce IL-6 following the upregulation of JNK activation. They respond poorly to phorbol ester and TNF via the NF-κB pathway. They have lower levels of IKKα subunit, potentially accounting for impairments of p100 processing and the alternative NF-κB pathway. The loss of EVER2 is associated with an unusual TRAF protein profile. We demonstrate that EVER2 deficiency sustains TRAF2 ubiquitination and decreases the pool of TRAF2 available in the detergent-soluble fraction of the cell. Finally, we demonstrate that EVER2 loss induces constitutive PKCα-dependent c-jun phosphorylation and facilitates activation of the HPV5 long control region through a JNK-dependent pathway. These findings indicate that defects of the EVER2 gene may create an environment conducive to HPV replication and the persistence of lesions with the potential to develop into skin cancer.
first_indexed 2024-12-14T08:05:00Z
format Article
id doaj.art-0e7a557c92fc4eff9e557c86b7f89b1c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T08:05:00Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-0e7a557c92fc4eff9e557c86b7f89b1c2022-12-21T23:10:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8947910.1371/journal.pone.0089479Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.Françoise VuillierGuillaume GaudDelphine GuillemotPierre-Henri CommereChristian PonsMichel FavreHomozygous mutations in EVER genes cause epidermodysplasia verruciformis (EV), characterized by an immune defect and the development of skin cancers associated with β-human papillomavirus (HPV) infections. The effects of EVER protein loss on the keratinocyte immune response remain unknown. We show here that EVER2 plays a critical role in the interplay between the NF-κB and JNK/AP-1 signaling pathways. EVER2-deficient cells overproduce IL-6 following the upregulation of JNK activation. They respond poorly to phorbol ester and TNF via the NF-κB pathway. They have lower levels of IKKα subunit, potentially accounting for impairments of p100 processing and the alternative NF-κB pathway. The loss of EVER2 is associated with an unusual TRAF protein profile. We demonstrate that EVER2 deficiency sustains TRAF2 ubiquitination and decreases the pool of TRAF2 available in the detergent-soluble fraction of the cell. Finally, we demonstrate that EVER2 loss induces constitutive PKCα-dependent c-jun phosphorylation and facilitates activation of the HPV5 long control region through a JNK-dependent pathway. These findings indicate that defects of the EVER2 gene may create an environment conducive to HPV replication and the persistence of lesions with the potential to develop into skin cancer.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586810/?tool=EBI
spellingShingle Françoise Vuillier
Guillaume Gaud
Delphine Guillemot
Pierre-Henri Commere
Christian Pons
Michel Favre
Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
PLoS ONE
title Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
title_full Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
title_fullStr Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
title_full_unstemmed Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
title_short Loss of the HPV-infection resistance EVER2 protein impairs NF-κB signaling pathways in keratinocytes.
title_sort loss of the hpv infection resistance ever2 protein impairs nf κb signaling pathways in keratinocytes
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586810/?tool=EBI
work_keys_str_mv AT francoisevuillier lossofthehpvinfectionresistanceever2proteinimpairsnfkbsignalingpathwaysinkeratinocytes
AT guillaumegaud lossofthehpvinfectionresistanceever2proteinimpairsnfkbsignalingpathwaysinkeratinocytes
AT delphineguillemot lossofthehpvinfectionresistanceever2proteinimpairsnfkbsignalingpathwaysinkeratinocytes
AT pierrehenricommere lossofthehpvinfectionresistanceever2proteinimpairsnfkbsignalingpathwaysinkeratinocytes
AT christianpons lossofthehpvinfectionresistanceever2proteinimpairsnfkbsignalingpathwaysinkeratinocytes
AT michelfavre lossofthehpvinfectionresistanceever2proteinimpairsnfkbsignalingpathwaysinkeratinocytes